NASDAQ (USD): Landos Biopharma, Inc. (LABP)
Last Price
22.93
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Manufacturing Mired in Weakness; Prices Paid Gauge Hits Six-month Low
2
US Supreme Court Rules Trump Has Immunity for Official, Not Private Acts
3
BYD Sales Rise to a Record on Price Cuts, Tech Upgrades
4
Morgan Stanley Doing Away With Bonus Caps for City of London Staff
5
Biden Loyalists Dismiss Calls to Quit in Frenetic Weekend Blitz
#
Stock
Score
TQQQ
ProShares UltraPro QQQ
SQQQ
ProShares UltraPro Short QQQ
800
CSLR
Complete Solaria, Inc.
OPTT
Ocean Power Technologies, Inc.
NVDA
NVIDIA Corporation
320
6
AGN
300
7
BAC
Bank of America Corporation
200
8
LGND
Ligand Pharmaceuticals Incorporated
9
AAPL
Apple Inc.
10
BABA
Alibaba Group Holding Limited
140
Last
Change
Volume
0.482
+0.206
485,876,453
TSLA
228.06
+18.20
147,749,234
123.16
-1.14
144,150,292
LMDX
0.016
-0.018
120,553,903
MAXN
0.184
-0.365
106,726,721
RDZN
2.83
+1.21
94,648,971
762.00
-84.71
85,558,284
TSLL
12.07
+1.78
78,830,028
7.96
-0.155
75,573,102
MU
132.23
-10.13
65,857,209
FCNCA
1,733.57
+36.01
30,480
AZO
2,860.67
+27.88
55,026
FNGU
494.24
+20.89
728,289
BKNG
3,904.61
+19.73
50,018
SMCI
832.00
+19.68
4,304,211
ORLY
1,032.31
+15.99
166,968
WSO
475.62
+13.67
97,183
FICO
1,509.65
+13.14
45,268
GWW
908.27
+12.08
84,015
MSTR
1,065.03
-227.94
2,455,399
MELI
1,629.32
-188.66
1,851,535
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
BRK-A
610,385.00
-75.00
1,078
MDB
236.06
-73.94
10,812,930
1,016.32
-39.74
532,341
1,333.47
-32.494
501,594
SEB
3,072.10
-32.47
2,057
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....